Plunkett Research Online: Oncolytics Biotech, Inc.

ONCOLYTICS BIOTECH, INC. (ONCYF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Oncolytics Biotech Inc is a development stage biotechnology company. It focuses on discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its main product is Reolysin. The company also has patents issued worldwide, mainly in US.....



Oncolytics Biotech, Inc.
Ticker: ONCYF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 403 670-7377
Fax: 1 403 283-0858
Address: 1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7 Canada

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Kirk LookCFO
Wayne PisanoChairman of the Board/Director
See More
Oncolytics Biotech Inc is a development stage biotechnology company. It focuses on discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its main product is Reolysin. The company also has patents issued worldwide, mainly in US.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: